Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Profile for Germany Patent: 602006011310

See Plans and Pricing

« Back to Dashboard

US Patent Family Members and Approved Drugs for Germany Patent: 602006011310

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
  Start Trial Apr 15, 2027 Boehringer Ingelheim SYNJARDY XR empagliflozin; metformin hydrochloride
  Start Trial Apr 15, 2027 Boehringer Ingelheim GLYXAMBI empagliflozin; linagliptin
  Start Trial Apr 15, 2027 Boehringer Ingelheim JARDIANCE empagliflozin
  Start Trial Apr 15, 2027 Boehringer Ingelheim SYNJARDY empagliflozin; metformin hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.